Abasaglar ® (basal insulin glargine)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information: Abasaglar Summary of Product Characteristics (SmPC)

Abasaglar® (insulin glargine injection): KwikPen Device

The Abasaglar KwikPen is a multiple-dose prefilled disposable pen containing 300 units (3 mL) of insulin glargine.

Detailed Information on the KwikPen device

Abasaglar is available as a 3-mL prefilled disposable pen (KwikPen®) containing 300 units of insulin glargine (Figure 1).1,2

Figure 1. Abasaglar® KwikPen®2

Priming ensures the Pen is ready to dose and removes air that may collect in the needle and cartridge during normal use. If the Pen is not primed before each injection, the patient may get too much or too little insulin.2

A new needle must be used for each injection to help prevent infection and obstructed needles.2

One to 80 insulin units may be administered from a single injection of the Pen.2

If the prescribed dose is more than 80 units, the patient will need more than one injection.2

If the patient’s dose exceeds the number of insulin units left in the Pen, the patient may inject the amount left in the Pen and then use a new Pen to give the rest of the dose or get a new Pen and inject the full dose. The Pen will not allow the patient to dial more than the number of insulin units left in the cartridge. A small amount of insulin will remain in the Pen that cannot be injected.2

Safe Use of the KwikPen

The patient should not use the Pen if any part looks broken or damaged.2

If the Pen cap is unable to be removed, the patient should gently twist the cap back and forth and then pull the cap straight off. 2

If the dose knob is hard to push, the patient should try the following:

  • the needle may be blocked. Install a new needle and prime the Pen

  • there may be dust, food, or liquid inside the KwikPen. Throw away the Pen and use a new one

  • push the dose knob more slowly, which should make the injection easier.2

In order to prevent the spread of infections, the Pen must never be shared between patients even if the needle is changed.2

The Pen is not recommended for use by patients who are blind or visually impaired without the help of someone trained to use the Pen.2


1. Abasaglar [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.

2. Abasaglar [instructions for use]. Eli Lilly Nederland B.V., The Netherlands .


Abasaglar = Abasaglar® (insulin glargine) 100 units/mL

Pen = KwikPen®

Date of Last Review: April 25, 2018

Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com

Available Mon - Fri, 8am - 4pm, excluding Bank Holidays

Or you can

Chat with Us If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a question